Grace Therapeutics GRCE
NASDAQ GRCE
$1.96 -0.02 (-1.01%)
As of: Oct 21, 2026 · 11:23 AM EDT

Grace Therapeutics (GRCE) Revenue (2020 - 2026)

Updated

Grace Therapeutics (GRCE) posted Revenue of $115,000 for fiscal Q4 2021 (quarter ended Mar 31, 2021), up 42.0% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Revenue (2020 - 2026) Analysis & Trends

For FY2021 (ended Mar 31, 2021), Grace Therapeutics' Revenue came in at $196,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 25.31 Bn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 16.99 Bn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 15.38 Bn
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 7.80 Bn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 15.03 Bn
10 Grace Therapeutics 33.85 Mn -32.42 Mn - 141,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 141,000.00
Mar 31, 2026 138,000.00
Dec 31, 2025 172,000.00
Sep 30, 2025 172,000.00
Jun 30, 2025 204,000.00
Mar 31, 2025 184,000.00
Dec 31, 2024 127,000.00
Sep 30, 2024 182,000.00
Jun 30, 2024 235,000.00
Mar 31, 2021 115,000.00
Dec 31, 2020 81,000.00
API Access

Grace Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=GRCE&period=max&api_key=YOUR_API_KEY